Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: KAKALAK who wrote (2631)	7/22/1998 9:31:00 AM
From: Bruce Rozenblit	Respond to of 3725

This will do wonders for bottom line. HeartScan has lost 8 million per year for the last two years and probably do the same this year. That means Imat has to sell at least 10 scanners each year at full margin just to generate enough profit to cover the losses. When you are selling less than 25 machines a year, that is a HUGE loss. If it wasn't for the mounting losses, the company would be at break even or maybe plus one cent a share per quarter. The problems of the last quarter of 97 and first of 98 were caused by circumstances the company couldn't control or avoid. The way the stock market works, a company that has no earnings is just a concept. A company that generates profits is the real thing. That's why I have been so upset with HeartScan because the most important and largest earnings gap any company must traverse is from minus 1 cent to plus 1 cent. As soon as this thing goes positive and stays there, our wallets should fatten up.